What is DERM's current stock price?

DERM (Journey Medical Corporation) is currently trading at $5.96 with a market cap of $164.0M.

What sector is Journey Medical Corporation in?

Journey Medical Corporation (DERM) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

Is DERM a good stock to buy?

Analysts have a Buy consensus on DERM with a price target of $11.75. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

DERM Journey Medical Corporation

Healthcare

$5.96-4.03%ClosedMarket Cap: $164.0M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

5.28

P/S

2.54

EV/EBITDA

-90.05

DCF Value

$-7.65

FCF Yield

-4.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

60.4%

Operating Margin

-9.8%

Net Margin

-14.8%

ROE

-35.6%

ROA

-10.5%

ROIC

-11.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$16.0M	$-2.2M	$—
Q4 null	$16.1M	$-1.2M	$—
FY null	$61.9M	$-11.4M	$—
Q3 null	$17.6M	$-2.3M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$11.75

Target (Median)

$11.75

Target Range

$10.50 - $13.00

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-03-26

Lake StreetBuy

2025-08-13

B. Riley SecuritiesBuy

2025-07-30

Trading Activity

Insider Trades

View All

Maraoui Claudedirector, officer: President & CEO

SellFri Apr 24

Maraoui Claudedirector, officer: President & CEO

SellFri Apr 24

Benesch Josephofficer: CFO

SellFri Apr 24

Benesch Josephofficer: CFO

SellFri Apr 24

Alloush Ramseyofficer: Chief Operating Officer

SellFri Apr 24

Latest News

Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research · Thu Mar 26

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

1.03

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Peers

IVA

OGI